veteran using Nerivio at VA office

The Department of Veterans Affairs reports that veterans are more likely to experience migraine than civilians.1

The Global Burden of Disease (GBD) study of 2016 ranks migraine, in years of life lived with disability, as the second most disabling disorder globally.2

Nerivio VA Ordering Information
veteran using Nerivio at VA office mobile

Nerivio really helped me !

To order Nerivio, please follow these steps

1. Medical Provider submits order to Prosthetics/Pharmacy

Product Description # of devices
A. Item #: FGD000075 One Month of Treatment 1
B. Item #: Nerivio 3 Three Months of Treatment 3
C. Item #: Nerivio 6 Six Months of Treatment 6
D. Item #: Nerivio 12 Twelve Months of Treatment 12

FSS #: 36F79721D0103

2. Prosthetics sends the PO for Nerivio

ORDERING CONTACT:

Veterans Medical Distributors, Inc.

Email: [email protected]

Phone: (561)588-3222

 

Drug-free, easy-to-use, non-invasive wearable device to treat and prevent migraine

female veteran waring Nerivio
female veteran waring Nerivio

EFFECTIVE

66.7% of patients  found relief from their migraine pain at 2 hrs post treatment.(3)

4 migraine days reduction when used every other day.(5)

SAFE

96.4% of patients studied did not report any device related side effects.(3)

0 device-related adverse events reported in pivotal prevention trial. (5)

EASY-TO-USE

89.7% of patients opted to treat with REN (Nerivio) to avoid medication use.(4)

Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older. It is a prescription use, self-administered device for use in the home environment at the onset of migraine headache or aura for acute treatment, or every other day for preventive treatment. Nerivio should not be used by people with uncontrolled epilepsy, an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device. Such use could cause electric shock, electrical interference or serious injuries or medical conditions. Nerivio has not been evaluated in people with congestive heart failure (CHF), severe cardiac or cerebrovascular disease, for pregnancy, or those under the age of 12. Nerivio should only be applied on the upper arm over dry, healthy skin with normal physical sensation and without any metallic implants or in proximity to cancerous lesions. For full user instructions and safety information, please see the Nerivio User Manual.

    1. https://americanmigrainefoundation.org/resource-library/veterans-and-migraine/
    2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. doi:10.1016/S1474-4422(18)30322-3
    3. Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019;59(8): 1240-1252
    4. Marmura MJ, Lin T, Harris D, lroni A, Rosen NL. Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication. Use: An Open-Label Extension Study. Frontiers in Neurology. 2020; 11 :226
    5. Tepper SJ, et al. Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. Headache. 2023. doi: 10.1111/head.14469.